the InvivoSciences' mission is the research and development of engineered tissue-based assays that are superior because they mimic the functions of living organisms, specifically, those of animals and humans. Designed to meet the increasing demand for efficacy and productivity in the areas of drug discovery and life sciences research, we provide automated, real-time, high-content and highly sensitive detection systems that are as predictive and cost effective as they are revolutionary. Most current in vitro drug testing methods use two-dimensional (2D) cell cultures that do not take into account the impact of the physical environment in which cells grow. This results in unsatisfactory, sometimes misleading and non-predictive data for in vivo responses. The ready-to-use tissues and assay platforms produced by InvivoSciences provide three-dimensional (3D) geometrics and physical environments for cells, bridging the gap between cell-based systems and isolated organ tissue systems or animal models, and can therefore act as model systems for chemical screening assays. This provides researchers with screening strategies that can assess the potential toxicity of new drugs--including those for cardiac applications--in accurate, predictive detection environments requiring less time and cost than corresponding studies using animals. On Mar 24-25, 2009, InvivoSciences presented its technology and business model at the World's Best Technology showcase in Texas. InvivoSciences was among the top 3 award winners at the showcase. The company was selected by investors, licensees, and tech-commercialization experts to receive the "gold" award. Visit http://www.wbtshowcase.com/wbt/web.nsf/pages/index.html for more information. InvivoSciences has also received 2012 Edison Awards.